Find a Tender
complete
Official procurement procedure
NHS National Generic Pharmaceuticals - Wave 15c
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Generic Pharmaceuticals - Wave 15c". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published26 Feb 2026, 11:26 GMT | Last source update26 Feb 2026, 11:26 GMT | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-05193a | ||
What is being bought
NHS National Framework for Generic Pharmaceuticals - Wave 15c
Offer reference number: CM/PHG/23/5699
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/01 Oral (plus non-parenteral) products
CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months)
CM/PHG/23/5699/02 Hospital only products
DLS: 01/06/2026 to 31/05/2028 (24 months)
DNE: 01/06/2026 to 31/05/2028 (24 months)
CM/PHG/23/5699/03 Hospital only (housekeeping) products
DLN/DNW 01/06/2026 to 31/01/2027 (8 months)
DCE/DSW 01/06/2026 to 30/09/2027 (16 months)
What changed
From the official release history
- Official notice release published
26 Feb 2026, 11:26 GMT - tender value changed
14 Jan 2026, 09:18 GMT - Status changed to complete
14 Jan 2026, 09:18 GMT - Official notice release published
14 Jan 2026, 09:18 GMT - Submission deadline changed to published date
14 Jan 2026, 09:18 GMT - Official notice release published
10 Sept 2025, 14:19 BST - Official notice release published
10 Sept 2025, 14:00 BST - Submission deadline changed to 10 Oct 2025, 13:00 BST
10 Sept 2025, 14:00 BST - Official notice release published
4 Sept 2025, 16:19 BST - Status changed to active
2 Sept 2025, 11:48 BST - Official notice release published
2 Sept 2025, 11:48 BST - Submission deadline changed to 2 Oct 2025, 13:00 BST
2 Sept 2025, 11:48 BST - Published value updated to £557,571,000
14 Aug 2025, 15:27 BST - Official notice release published
14 Aug 2025, 15:27 BST - Published value updated to £260,000,000
20 May 2025, 15:48 BST - Status changed to planned
20 May 2025, 15:48 BST - Official notice release published
20 May 2025, 15:48 BST - Buyer information updated
20 May 2025, 15:48 BST
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
26 Feb 2026, 11:26 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 28 Jan 2026, 00:00 GMT · £17,727,000 - Contract active
Signed 28 Jan 2026, 00:00 GMT · £403,702,000 - Contract active
Signed 28 Jan 2026, 00:00 GMT · £37,160,000
Commercial outcome and competition
Awards Amarox Limited, BROWN & BURK UK LIMITED, CELIX PHARMA LTD, CIPLA (EU) LIMITED, CONSILIENT HEALTH (UK) LIMITED, DR REDDY'S LABORATORIES (UK) LIMITED, FARMAK PHARMACEUTICALS UK LTD, MORNINGSIDE PHARMACEUTICALS LIMITED, NOVUMGEN LIMITED, ROCHE PRODUCTS LIMITED, ROSEMONT PHARMACEUTICALS LIMITED, RPH PHARMA LTD, SELECTIVE SUPPLIES LIMITED, TEVA UK LIMITED, VIATRIS UK HEALTHCARE LIMITED Not published · Not published · active AFT Pharma UK Limited, AGB Pharma (UK) Ltd, AOP Orphan Limited, ASCEND LABORATORIES (UK) LIMITED, ASCOT LABORATORIES LIMITED, ASPEN PHARMACARE UK LIMITED, ASPIRE PHARMA LIMITED, AVENTIS PHARMA LIMITED t-a Sanofi, Accord UK Ltd, Aguettant Limited, Alturix Limited, Amarox Limited, Arcadia Pharma Limited, B. BRAUN MEDICAL LIMITED, BAXTER HEALTHCARE LIMITED Not published · Not published · active ASPIRE PHARMA LIMITED, Accord UK Ltd, BAXTER HEALTHCARE LIMITED, BOWMED IBISQUS LIMITED, Beaumont Pharma Ltd, Biocon Pharma UK Limited, ESTEVE PHARMACEUTICALS LTD, FARMAK PHARMACEUTICALS UK LTD, GLENMARK PHARMACEUTICALS EUROPE LIMITED, GRINDEKS KALCEKS UK LIMITED, Green Park Pharma Ltd, HAMELN PHARMA LTD, HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED, JCSH Pharma Ltd, KENT PHARMA UK LIMITED Not published · Not published · active |
Contracts Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products £17,727,000 · signed 28 Jan 2026, 00:00 GMT · active Contract period: 1 Jun 2026, 00:00 BST — 31 May 2027, 23:59 BST Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products £403,702,000 · signed 28 Jan 2026, 00:00 GMT · active Contract period: 1 Jun 2026, 00:00 BST — 31 May 2028, 23:59 BST Lot 3 - CM/PHG/23/5699/03 Hospital only (housekeeping) products £37,160,000 · signed 28 Jan 2026, 00:00 GMT · active Contract period: 1 Jun 2026, 00:00 BST — 30 Sept 2027, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Showing primary 50 of 106 published organisations
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published